These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 19469177
21. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatology; 1998 Jan; 27(1):213-22. PubMed ID: 9425940 [Abstract] [Full Text] [Related]
22. Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B. Roche B, Samuel D. Transpl Int; 2005 May; 17(12):746-58. PubMed ID: 15688165 [Abstract] [Full Text] [Related]
23. Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years. Yilmaz N, Shiffman ML, Todd Stravitz R, Sterling RK, Luketic VA, Sanyal AJ, Maluf D, Coterell A, Posner MP, Fisher RA. Liver Int; 2008 Jan; 28(1):72-8. PubMed ID: 17983429 [Abstract] [Full Text] [Related]
24. Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience. Roche B, Samuel D, Feray C, Majno P, Gigou M, Reynes M, Bismuth H. Liver Transpl Surg; 1999 May; 5(3):166-74. PubMed ID: 10226106 [Abstract] [Full Text] [Related]
25. Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Lo CM, Fan ST, Liu CL, Lai CL, Wong J. Transplantation; 2003 Feb 15; 75(3 Suppl):S41-4. PubMed ID: 12589139 [Abstract] [Full Text] [Related]
26. Prevention of hepatitis B virus recurrence after liver transplantation. Eisenbach C, Sauer P, Mehrabi A, Stremmel W, Encke J. Clin Transplant; 2006 Feb 15; 20 Suppl 17():111-6. PubMed ID: 17100710 [Abstract] [Full Text] [Related]
27. [Prevention and treatment of hepatitis B recurrence after liver transplantation]. Zhang XL, Zhu XF, Shi HJ, Cui SZ, Tang YQ, Ba MC, Wang JK, Wang B, Lu Q, Zhao HY, Wu YB, Li ML. Zhonghua Yi Xue Za Zhi; 2008 Mar 04; 88(9):606-9. PubMed ID: 18646715 [Abstract] [Full Text] [Related]
28. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Liver Transpl; 2006 May 04; 12(5):801-7. PubMed ID: 16628690 [Abstract] [Full Text] [Related]
29. Living donor liver transplantation for hepatitis B cirrhosis. Karasu Z, Akyildiz M, Kilic M, Zeytunlu M, Aydin U, Tekin F, Yilmaz F, Ozacar T, Akarca U, Ersoz G, Gunsar F, Ilter T, Lucey MR. J Gastroenterol Hepatol; 2007 Dec 04; 22(12):2124-9. PubMed ID: 18031369 [Abstract] [Full Text] [Related]
30. Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins. Di Paolo D, Lenci I, Trinito MO, Carbone M, Longhi C, Tisone G, Angelico M. Dig Liver Dis; 2006 Oct 04; 38(10):749-54. PubMed ID: 16916630 [Abstract] [Full Text] [Related]
31. Role of liver transplantation in patients with hepatitis B infection. Holt CD, Millis JM, Busuttil RW. Clin Transplant; 1995 Jun 04; 9(3 Pt 2):269-76. PubMed ID: 7670175 [Abstract] [Full Text] [Related]
32. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb 04; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related]
33. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation. Takaki A, Yagi T, Iwasaki Y, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, Umeda Y, Miyake Y, Terada R, Kobashi H, Sakaguchi K, Tanaka N, Shiratori Y. Transplantation; 2007 Jan 27; 83(2):231-3. PubMed ID: 17264822 [Abstract] [Full Text] [Related]
34. HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence. Karasu Z, Ozacar T, Akarca U, Ersoz G, Erensoy S, Gunsar F, Kobat A, Tokat Y, Batur Y. J Viral Hepat; 2005 Mar 27; 12(2):212-5. PubMed ID: 15720538 [Abstract] [Full Text] [Related]
35. [Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment]. Jiao ZY, Yan LN, Li B, Zeng Y, Wen TF, Lu SC, Zhao JC, Wang WT, Xu MQ, Yang JY, Li ZH, Ma YK, Zhang ZW, Chen ZY. Zhonghua Gan Zang Bing Za Zhi; 2007 Nov 27; 15(11):804-8. PubMed ID: 18073060 [Abstract] [Full Text] [Related]
36. [An analysis of long term prophylaxis of virus recurrence with antiviral treatment in HBV infected liver transplant recipient patients]. Dai J, Lu SC, Yan LN, Li B, Lai W, Zhao J, Jin SJ, Wen TF, Zhao JC, Zeng Y, Gu M, Tao CM, Zhang XH. Zhonghua Gan Zang Bing Za Zhi; 2007 Sep 27; 15(9):663-6. PubMed ID: 17903367 [Abstract] [Full Text] [Related]
37. Liver transplantation for patients with hepatitis B virus-related diseases. Huang J, He X, Zhu X, Chen G. Zhonghua Wai Ke Za Zhi; 2001 Oct 27; 39(10):737-41. PubMed ID: 16201183 [Abstract] [Full Text] [Related]
38. Preoperative lamivudine therapy in HBV DNA positive recipients: is it always necessary? Lee HW, Suh KS, Yi NJ, Yang SH, Cho EH, Cho JY, Kwon CH, Cho YB, Lee KU. Hepatogastroenterology; 2007 Sep 27; 54(78):1783-7. PubMed ID: 18019718 [Abstract] [Full Text] [Related]
40. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen. Ahn HJ, Kim MS, Kim YS, Kim SI, Huh KH, Ju MK, Ahn SH, Han KH. J Med Virol; 2007 Nov 27; 79(11):1655-63. PubMed ID: 17854044 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]